bunazosin has been researched along with Cardiac Failure in 11 studies
bunazosin: structure
| Excerpt | Relevance | Reference |
|---|---|---|
| " Hemodynamic responses to Bunazosin (BZN) in congestive heart failure (CHF) were evaluated for 6 hours (hr) in 30 patients (A, normal cardiac function; B, mild cardiac dysfunction; C, severe cardiac dysfunction)." | 7.68 | Acute hemodynamic effects of bunazosin in congestive heart failure--differing responses according to degree of cardiac dysfunction. ( Kato, M; Kinugawa, T; Kitamura, H; Kotake, H; Mashiba, H; Matsumoto, T; Miyakoda, H; Noguchi, N; Ogino, K; Osaki, S, 1993) |
| "The purpose of this study was to investigate the therapeutic effect of an alpha 1-blocker, bunazosin, using an experimental murine model of congestive heart failure induced by viral myocarditis." | 7.68 | The effect of alpha 1-blocker, bunazosin on a murine model of congestive heart failure induced by viral myocarditis. ( Kawai, C; Matsumori, A; Okada, I; Tominaga, M; Yamada, T, 1992) |
| "To study the effect of bunazosin on exercise capacity in patients with congestive heart failure (NYHA II-III), anaerobic thresholds (AT, VO2, ml/min/kg) were measured before (control) and after initial 1 = 2mg administration of bunazosin (acute phase; N = 14) and after two weeks of bunazosin therapy (3mg/day, 1mg t." | 7.68 | [The acute and chronic effects of bunazosin on exercise capacity estimated by the anaerobic threshold in patients with chronic congestive heart failure]. ( Hosoda, S; Kaneko, N; Kawagoe, Y; Kimata, S; Kimura, H; Konno, K; Miki, N; Nagashima, H; Sumiyoshi, T, 1992) |
| "The acute hemodynamic effect (right atrial pressure, mean pulmonary artery pressure, pulmonary capillary wedge pressure, cardiac index, heart rate, blood pressure) and neurohumoral response (alpha-ANP, plasma renin activity, aldosterone, angiotensin II) of Bunazosin, oral alpha 1 blocker, was investigated in 28 patients with congestive heart failure at rest and immediately after exercise." | 7.67 | [Acute and chronic effects of bunazosin in patients with congestive heart failure]. ( Hasegawa, K; Inoue, S; Kawahara, Y; Nezuo, S; Sawayama, T; Tadaoka, S, 1989) |
| "The hemodynamic parameters (right atrial pressure, mean pulmonary artery pressure, pulmonary capillary wedge pressure, cardiac index, heart rate, blood pressure) and neurohumoral responses (alpha-ANP, plasma renin activity, aldosterone, angiotensin II) of Captopril, oral ACE inhibitor, and Bunazosin, oral alpha 1-blocker, were investigated in 28 patients with congestive heart failure at rest and after exercise." | 7.67 | [The effect of bunazosin vs captopril on hemodynamic and neurohumoral parameters in patients with congestive heart failure]. ( Hasegawa, K; Inoue, S; Kakumae, S; Kawahara, Y; Nakamura, T; Nakao, M; Nezuo, S; Sawayama, T; Tadaoka, S, 1989) |
| " Hemodynamic responses to Bunazosin (BZN) in congestive heart failure (CHF) were evaluated for 6 hours (hr) in 30 patients (A, normal cardiac function; B, mild cardiac dysfunction; C, severe cardiac dysfunction)." | 3.68 | Acute hemodynamic effects of bunazosin in congestive heart failure--differing responses according to degree of cardiac dysfunction. ( Kato, M; Kinugawa, T; Kitamura, H; Kotake, H; Mashiba, H; Matsumoto, T; Miyakoda, H; Noguchi, N; Ogino, K; Osaki, S, 1993) |
| "The purpose of this study was to investigate the therapeutic effect of an alpha 1-blocker, bunazosin, using an experimental murine model of congestive heart failure induced by viral myocarditis." | 3.68 | The effect of alpha 1-blocker, bunazosin on a murine model of congestive heart failure induced by viral myocarditis. ( Kawai, C; Matsumori, A; Okada, I; Tominaga, M; Yamada, T, 1992) |
| "To study the effect of bunazosin on exercise capacity in patients with congestive heart failure (NYHA II-III), anaerobic thresholds (AT, VO2, ml/min/kg) were measured before (control) and after initial 1 = 2mg administration of bunazosin (acute phase; N = 14) and after two weeks of bunazosin therapy (3mg/day, 1mg t." | 3.68 | [The acute and chronic effects of bunazosin on exercise capacity estimated by the anaerobic threshold in patients with chronic congestive heart failure]. ( Hosoda, S; Kaneko, N; Kawagoe, Y; Kimata, S; Kimura, H; Konno, K; Miki, N; Nagashima, H; Sumiyoshi, T, 1992) |
| "The acute hemodynamic effect (right atrial pressure, mean pulmonary artery pressure, pulmonary capillary wedge pressure, cardiac index, heart rate, blood pressure) and neurohumoral response (alpha-ANP, plasma renin activity, aldosterone, angiotensin II) of Bunazosin, oral alpha 1 blocker, was investigated in 28 patients with congestive heart failure at rest and immediately after exercise." | 3.67 | [Acute and chronic effects of bunazosin in patients with congestive heart failure]. ( Hasegawa, K; Inoue, S; Kawahara, Y; Nezuo, S; Sawayama, T; Tadaoka, S, 1989) |
| "The hemodynamic parameters (right atrial pressure, mean pulmonary artery pressure, pulmonary capillary wedge pressure, cardiac index, heart rate, blood pressure) and neurohumoral responses (alpha-ANP, plasma renin activity, aldosterone, angiotensin II) of Captopril, oral ACE inhibitor, and Bunazosin, oral alpha 1-blocker, were investigated in 28 patients with congestive heart failure at rest and after exercise." | 3.67 | [The effect of bunazosin vs captopril on hemodynamic and neurohumoral parameters in patients with congestive heart failure]. ( Hasegawa, K; Inoue, S; Kakumae, S; Kawahara, Y; Nakamura, T; Nakao, M; Nezuo, S; Sawayama, T; Tadaoka, S, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (54.55) | 18.7374 |
| 1990's | 4 (36.36) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tamagawa, K | 1 |
| Saito, T | 1 |
| Oikawa, Y | 1 |
| Maehara, K | 1 |
| Yaoita, H | 1 |
| Maruyama, Y | 1 |
| Itoh, K | 1 |
| Kohya, T | 1 |
| Nishijima, H | 1 |
| Yasuda, H | 1 |
| Minami, S | 1 |
| Tsujinaga, H | 1 |
| Morimoto, Y | 2 |
| Noda, E | 1 |
| Yamamori, M | 1 |
| Nakai, K | 1 |
| Konishi, T | 2 |
| Kawanami, C | 1 |
| Hamada, M | 1 |
| Nakano, T | 2 |
| Takezawa, H | 2 |
| Ogino, K | 1 |
| Noguchi, N | 1 |
| Osaki, S | 1 |
| Kitamura, H | 1 |
| Matsumoto, T | 1 |
| Kato, M | 1 |
| Kinugawa, T | 1 |
| Miyakoda, H | 1 |
| Kotake, H | 1 |
| Mashiba, H | 1 |
| Takahashi, M | 1 |
| Shichiri, G | 1 |
| Amano, M | 1 |
| Kanamori, T | 1 |
| Kinoshita, M | 1 |
| Yamada, T | 1 |
| Matsumori, A | 1 |
| Okada, I | 1 |
| Tominaga, M | 1 |
| Kawai, C | 1 |
| Kawagoe, Y | 1 |
| Kimura, H | 1 |
| Kaneko, N | 1 |
| Sumiyoshi, T | 1 |
| Nagashima, H | 1 |
| Kimata, S | 1 |
| Hosoda, S | 1 |
| Konno, K | 1 |
| Miki, N | 1 |
| Kawahara, Y | 2 |
| Hasegawa, K | 2 |
| Sawayama, T | 2 |
| Nezuo, S | 2 |
| Inoue, S | 2 |
| Tadaoka, S | 2 |
| Okazaki, Y | 1 |
| Mishima, M | 1 |
| Hirayama, A | 1 |
| Komamura, K | 1 |
| Asada, S | 1 |
| Ohara, T | 1 |
| Lee, JM | 1 |
| Matsumura, Y | 1 |
| Yamamoto, K | 1 |
| Nishida, K | 1 |
| Nakamura, T | 1 |
| Kakumae, S | 1 |
| Nakao, M | 1 |
| Kakuta, Y | 1 |
| Makino, K | 1 |
| Umino, M | 1 |
| Nagano, K | 1 |
| Koyama, T | 1 |
| Kodera, T | 1 |
11 other studies available for bunazosin and Cardiac Failure
| Article | Year |
|---|---|
Alterations of alpha-adrenergic modulations of coronary microvascular tone in dogs with heart failure.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Blood | 2005 |
[Acute effect of a new alpha 1-receptor blocking drug, E-643, on severe congestive heart failure--pharmacokinetic and hemodynamic studies].
Topics: Adolescent; Adrenergic alpha-Antagonists; Adult; Aged; Drug Evaluation; Female; Heart Failure; Hemod | 1983 |
[Acute effects of a new antihypertensive quinazoline derivative, E-643 in severe heart failure--hemodynamics, plasma catecholamine levels and blood gas data (author's transl)].
Topics: Adult; Aged; Catecholamines; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Quinazo | 1981 |
Acute hemodynamic effects of bunazosin in congestive heart failure--differing responses according to degree of cardiac dysfunction.
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Blood Pressure; Female; Heart; Heart Failure; Heart Rate; | 1993 |
Increased uncoupling of beta-, beta 1- and beta 2-adrenoceptor to myocardial contraction in failing human myocardium.
Topics: Adult; Aged; Binding, Competitive; Dobutamine; Down-Regulation; Female; Heart Failure; Humans; Iodoc | 1992 |
The effect of alpha 1-blocker, bunazosin on a murine model of congestive heart failure induced by viral myocarditis.
Topics: Adrenergic alpha-Antagonists; Animals; Disease Models, Animal; Encephalomyocarditis virus; Enterovir | 1992 |
[The acute and chronic effects of bunazosin on exercise capacity estimated by the anaerobic threshold in patients with chronic congestive heart failure].
Topics: Adult; Aged; Anaerobic Threshold; Chronic Disease; Exercise Test; Exercise Tolerance; Female; Heart | 1992 |
[Acute and chronic effects of bunazosin in patients with congestive heart failure].
Topics: Adrenergic alpha-Antagonists; Atrial Natriuretic Factor; Chronic Disease; Exercise Test; Female; Hea | 1989 |
[Acute effects of oral bunazosin-hydrochloride in acute heart failure].
Topics: Acute Disease; Administration, Oral; Adrenergic alpha-Antagonists; Aged; Female; Heart Failure; Hemo | 1989 |
[The effect of bunazosin vs captopril on hemodynamic and neurohumoral parameters in patients with congestive heart failure].
Topics: Adrenergic alpha-Antagonists; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; | 1989 |
[Effects of oral bunazosin hydrochloride on hemodynamic and metabolic responses to exercise (ergometer, 25W, 5 min) in patients with severe congestive heart failure].
Topics: Aged; Exercise Test; Female; Heart Failure; Hemodynamics; Humans; Male; Metabolism; Middle Aged; Qui | 1987 |